PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9596129-6	1998	Damage of Clara cells produced by methylcyclopentadienyl manganese tricarbonyl resulted in a significant decrease of CC16 in BALF but did not affect the serum levels of the protein.	2-methylcyclopentadienyl manganese tricarbonyl	34-78	methylthioadenosine phosphorylase	Rattus norvegicus	117-121	
10414398-5	1999	CC16 concentration (mean+/-sD in microg x L(-1)), measured by a sensitive latex immunoassay, was significantly reduced in BALF of all treated groups (IPO 380+/-100; MMT 730+/-200; ANTU 1,070+/-200; controls 1,700+/-470).	2-methylcyclopentadienyl manganese tricarbonyl	165-168	methylthioadenosine phosphorylase	Rattus norvegicus	0-4	
10414398-7	1999	In serum, by contrast, CC16 was significantly increased in all treated groups (IPO 31+/-7; MMT 22+/-12; ANTU 52+/-24; controls 15+/-6).	2-methylcyclopentadienyl manganese tricarbonyl	91-94	methylthioadenosine phosphorylase	Rattus norvegicus	23-27